ABSTRACT
Objective@#To investigate the trends in prevalence of depression symptoms among middle-aged and elderly residents at ages of 45 years and older in China from 2011 to 2018, so as to provide insights into depression prevention and control among middle-aged and elderly residents. @*Methods@#Demographic features and evaluation data of depressive symptoms were collected from middle-aged and elderly residents at ages of 45 years and older recorded during four follow-ups in the China Health and Retirement Longitudinal Study (CHARLS), and the depressive symptoms were screened using the Center for Epidemiological Studies Depression Scale (CES-D). Following sampling weights, non-response weights, and post-stratification weighting, the detection of depressive symptoms was analyzed among the middle-aged and elderly residents with different demographics, and the trends in prevalence of depressive symptoms were identified using annual percent change (APC). @*Results@#A total of 48 223 middle-aged and elderly residents were enrolled, including 12 624, 10 427, 12 144, and 13 028 residents in 2011, 2013, 2015 and 2018, with mean ages of (58.8±9.4), (58.9±9.2), (59.0±9.2), and (61.1±9.2) years, respectively. The prevalence of depressive symptoms was 34.5% (95%CI: 33.3%-35.8%), 29.6% (95%CI: 28.5%- 30.8%), 30.6% (95%CI: 29.4%-31.8%), and 35.0% (95%CI: 33.6%-36.4%) among middle-aged and elderly residents in 2011, 2013, 2015 and 2018, respectively, with no remarkable changing trends seen (APC=0.4%, t=0.188, P=0.868). Higher detection was seen among residents at advanced ages, among women than among men, among rural residents than among urban residents, among residents with lower educational levels, among widowed and unmarried residents than among married residents, among unemployed residents than among employees, and among residents that had lower per capita personal consumption expenditures than mean expenditures than among residents that had higher per capita personal consumption expenditures than mean expenditures (all P<0.05). @*Conclusions@#There were no obvious trends in prevalence of depressive symptoms among middle-aged and elderly residents in China from 2011 to 2018, and individuals with advanced ages, women, urban residents and those with low educational and economic levels should be given a high priority for depression control.
ABSTRACT
ABSTRACT: Introduction: Evidence shows a lag in adoption of evidence-based practices (EBPs) for substance abuse treatment and supports the need for studying the factors involved in this worldwide problem. Objective: This study aimed to assess the readiness and barriers to adopt EBPs for substance abuse in a sample of outpatient treatment centers of a newly created Mexican Clinical Trials Network. Method: An online survey was administered to directors (n = 8) and clinicians (n = 40) from seven outpatient treatment centers in Mexico. Questions were obtained from two surveys that had been implemented in the US to assess the same objectives. Results: Respondents reported being more ready to adopt Cognitive Behavioral Therapy (CBT, 83.3%) and Motivational Enhancement Therapy (MET, 79.1%), compared to 12 step facilitation (58.3%), couples therapy (56.2%), Brief Strategic Family Therapy (BSFT, 66.6%), and motivational incentives (60.4%). Directors had lower mean resistance to EBPs (11.8 vs. 17.4; p = 0.01) than clinicians. The biggest barriers identified by directors to EBP adoption were not having enough clinical staff, being unable to afford well-trained staff, not enough psychiatric and medical support. Discussion and conclusion: CBT and MET emerged as the most frequently used evidence based practices in the sites that are part of the Mexican Clinical Trials Network. Staff positive attitudes towards EBPs are critical for adoption.
RESUMEN: Introducción: La literatura demuestra una demora en la adopción de las practicas basadas en la evidencia (PBEs) para el tratamiento del abuso de sustancias y apoya la necesidad de estudiar los factores involucrados en este problema mundial. Objetivo: Este estudio evaluó la disponiblildad y las barreras de la adopción de PBE para el abuso de sustancias en una muestra de centros pertenencientes a la nueva Red Mexicana de Ensayos Clinicos. Método: Se administró una encuesta online a directores (n = 8) y a clinicos (n = 40) de siete centros de tratamiento ambulatorio para el tratamiento de las adicciones en México. Las preguntas se obtuvieron de dos encuestas que se administraron en los Estados Unidos con los mismos objetivos. Resultados: Los encuestados reportaron estar más dispuestos a la adopción de la Terapia Cognitivo Conductual (CBT,83.3%) y Terapia de Incremento Motivacional (MET, 79.1%),comparado con la facilitación de los 12 pasos (58.3%),terapia de pareja (56.2%), Terapia Familiar Breve y Estratégica (BSFT, 66.6%),e incentivos para la motivación (60.4%). Los directores tuvieron menor promedio de Resistencia a las PBEs (11.8 vs. 17.4; p = 0.01) que los clinicos. Las principales barreras identificadas por los directores fueron no tener suficiente personal clínico, no poder costear personal altamente entrenado, apoyo psiquiátrico y médico insuficiente. Discusión y conclusión: La CBT y la MET emergieron como las PBEs usadas con mayor frecuencia en centros que son parte de la Red Mexicana de Ensayos Clínicos. Las actitudes positivas del personal hacia las PBEs son críticas para la adopción.